Stay updated on Pembrolizumab + Idelalisib in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Idelalisib in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Idelalisib in Lung Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the trial's study details with an access-denied message. As a result, users cannot view the essential information about the NCT03257722 study on this page.
    Difference
    18%
    Check dated 2026-09-21T22:36:57.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.6, indicating a minor version update to the page template. This does not modify study details or other user-facing content.
    Difference
    0.1%
    Check dated 2026-08-31T18:01:02.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.5, replacing the prior v3.6.4, indicating a small platform/template update.
    Difference
    0.1%
    Check dated 2026-08-10T15:30:50.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4, indicating a minor update to the page or its underlying components reflected in the revision history.
    Difference
    0.1%
    Check dated 2026-07-27T06:35:23.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    No additions or deletions were provided. The page content about the study details remains unchanged.
    Difference
    0.1%
    Check dated 2026-07-12T22:38:43.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.2 to v3.6.3, indicating a minor metadata update to the page.
    Difference
    0.1%
    Check dated 2026-07-05T13:58:00.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Idelalisib in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Idelalisib in Lung Cancer Clinical Trial page.